<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD012568-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD012568-sec-0008"></div> <div class="table" id="CD012568-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 1.</span>Â <span class="table-title">Amoxicillin + metronidazole + SRP compared to SRP for the nonâsurgical treatment of periodontitis</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="7" rowspan="1" class="headercell"> <p><b>Amoxicillin + metronidazole + SRP compared to SRP for the nonâsurgical treatment of periodontitis</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> adults with periodontitis (chronic/aggressive)<br><b>Setting:</b> outpatient<br><b>Intervention:</b> amoxicillin + metronidazole + SRP<br><b>Comparison:</b> SRP </p> <p><b>Followâup:</b> â¥1 year </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Risk with control (SRP)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Risk difference with amoxicillin + metronidazole + SRP</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of closed pockets</b><br>(Longâterm improvement in chronic periodontitis) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>44</p> <p>(1 RCT<sup>a</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean percentage of closed pockets was 49.30%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 16.20% lower</p> <p>(25.87 lower to 6.53 lower)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>c,d</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>Based on our definition of minimally important clinical difference (MICD)<sup>f</sup>, only the results for percentage of closed pockets and of BOP showed an MICD favouring amoxicillin + metronidazole + SRP </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>CAL</b> </p> <p>(Longâterm</p> <p>improvement in chronic and aggressive periodontitis)<br>Assessed with: periodontal probe in mm </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>389</p> <p>(2 RCTs<sup>a,b</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean CAL was 3.85 mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 0.47 mm lower<br>(0.90 lower to 0.05 lower ) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>d,e</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Probing pocket depth</b> </p> <p>(Longâterm improvement in chronic and aggressive periodontitis)<br>Assessed with: periodontal probe in mm </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>389</p> <p>(2 RCTs<sup>a,b</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean probing pocket depth was 2.75 mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 0.30 mm lower<br>(0.42 lower to 0.18 lower ) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>d,e</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of BOP</b><br>(Longâterm improvement in chronic and aggressive periodontitis)<br>Assessed with: periodontal probe </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>389<br>(2 RCTs<sup>a,b</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean percentage of BOP was 29.45%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 8.06% lower<br>(14.26 lower to 1.85 lower) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>d,e</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Antimicrobial resistance</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included studies have not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>389<br>(2 RCTs<sup>a,b</sup>) </p> </td> <td align="left" valign="top" colspan="3" rowspan="1" class="table-tint table-highlight"> <p>Most common adverse events were mild gastrointestinal disturbances, nausea and vomiting, metallic taste, and diarrhoea in the intervention group. Control group reported adverse events like hypothermia, mild gastrointestinal symptoms, diarrhoea, vomiting, cramps, rashes, and weakness. Nausea after alcohol intake was reported in 1 participant from the intervention group </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>d,e</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Patientâreported quality of life changes</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included studies have not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup><b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI) </p> <p><b>BOP:</b> bleeding on probing; <b>CAL:</b> clinical attachment level; <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>MICD:</b> minimally important clinical difference; <b>RCT:</b> randomized controlled trial; <b>SRP:</b> scaling and root planing </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD012568-bbs2-0007">Borges 2017</a>.<br><sup>b</sup><a href="./references#CD012568-bbs2-0019">Harks 2015</a>.<br><sup>c</sup>Downgraded by 1 level due to unclear risk of bias.<br><sup>d</sup>Downgraded by 2 levels due to imprecision.<br><sup>e</sup>Downgraded by 2 levels due to risk of bias as studies showed unclear or high risk of bias.<br><sup>f</sup>We decided to use an MD of 1 mm as the MICD for CAL and probing pocket depth, and 5% for percentage of closed pockets and percentage of BOP, and respective 95% CI not to cross the line of no effect. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD012568-tbl-0002"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 2.</span>Â <span class="table-title">Metronidazole + SRP compared to SRP for the nonâsurgical treatment of periodontitis</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="7" rowspan="1" class="headercell"> <p><b>Metronidazole + SRP compared to SRP for the nonâsurgical treatment of periodontitis</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> adults with periodontitis (chronic/aggressive)<br><b>Setting:</b> outpatient<br><b>Intervention:</b> metronidazole + SRP<br><b>Comparison:</b> SRP </p> <p><b>Followâup:</b> â¥1 year </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Risk with control (SRP)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Risk difference with metronidazole + SRP</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of closed pockets</b><br>(Longâterm improvement in chronic periodontitis) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>22</p> <p>(1 RCT<sup>a</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean percentage of closed pockets was 52.80%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 12.20% lower<br>(29.23 lower to 4.83 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>d,e</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>Based on our definition of minimally important clinical difference (MICD)<sup>h</sup>, only the results for CAL and probing pocket depth showed an MICD favouring metronidazole + SRP </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>CAL</b><br>(Longâterm improvement in chronic and aggressive periodontitis)<br>Assessed with: periodontal probe in mm </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>71<br>(3 RCTs<sup>a,b,c</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 1.12 mm lower<br>(2.24 lower to 0) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>e,f,g</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Probing pocket depth</b><br>(Longâterm improvement in aggressive periodontitis)<br>Assessed with: periodontal probe in mm </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>47<br>(2 RCTs<sup>a,c</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean probing pocket depth was 4.11 mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 1.11 mm lower<br>(2.84 lower to 0.61 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>d,e,g</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of BOP</b><br>(Longâterm improvement in chronic periodontitis)<br>Assessed with: periodontal probe </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>22</p> <p>(1 RCT<sup>a</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean percentage of BOP was 44.92%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 6.90% lower<br>(22.10 lower to 8.30 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>d,e,g</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Antimicrobial resistance</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included studies have not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>71<br>(3 RCTs<sup>a,b,c</sup>) </p> </td> <td align="left" valign="top" colspan="3" rowspan="1" class="table-tint table-highlight"> <p>No severe adverse effects were reported by any of the participants in 1 study. 2 studies have not reported adverse events </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>e,f</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Patientâreported quality of life changes</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included studies have not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup><b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br><br><b>BOP:</b> bleeding on probing; <b>CAL:</b> clinical attachment level; <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>MICD:</b> minimally important clinical difference; <b>RCT:</b> randomized controlled trial; <b>SRP:</b> scaling and root planing </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD012568-bbs2-0008">Carvalho 2004</a>.<br><sup>b</sup><a href="./references#CD012568-bbs2-0036">Sigusch 2000</a>.<br><sup>c</sup><a href="./references#CD012568-bbs2-0037">Sigusch 2001</a>.<br><sup>d</sup>Downgraded by 1 level due to unclear risk of bias.<br><sup>e</sup>Downgraded by 2 levels due to imprecision.<br><sup>f</sup>Downgraded by 2 levels due to risk of bias as studies showed unclear or high risk of bias.<br><sup>g</sup>Downgraded by 1 level for inconsistency.<br><sup>h</sup>We decided to use an MD of 1 mm as the MICD for CAL and probing pocket depth, and 5% for percentage of closed pockets and percentage of BOP, and respective 95% CI not to cross the line of no effect. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD012568-tbl-0003"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 3.</span>Â <span class="table-title">Azithromycin + SRP compared to SRP for the nonâsurgical treatment of periodontitis</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="7" rowspan="1" class="headercell"> <p><b>Azithromycin + SRP compared to SRP for the nonâsurgical treatment of periodontitis</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> adults with periodontitis (chronic/aggressive)<br><b>Setting:</b> outpatient<br><b>Intervention:</b> azithromycin + SRP<br><b>Comparison:</b> SRP </p> <p><b>Followâup:</b> â¥1 year </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Risk with control (SRP)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Risk difference with azithromycin + SRP</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of closed pockets</b><br>(Longâterm improvement in chronic periodontitis) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>40</p> <p>(1 RCT<sup>a</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean percentage of closed pockets was 51.50%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 2.50% higher<br>(10.19 lower to 15.19 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>c,d,e</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>Based on our definition of minimally important clinical difference (MICD)<sup>g</sup>, we found no evidence of a difference between intervention and control </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>CAL</b><br>(Longâterm improvement in chronic and aggressive periodontitis)<br>Assessed with: periodontal probe in mm </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>110<br>(2 RCTs<sup>a,b</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean CAL was 5.30 mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 0.59 mm lower<br>(1.27 lower to 0.08 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>c,e,f</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Probing pocket depth</b><br>(Longâterm improvement in chronic and aggressive periodontitis)<br>Assessed with: periodontal probe in mm </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>110<br>(2 RCTs<sup>a,b</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean probing pocket depth was 4.29 mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 0.77 mm lower<br>(2.33 lower to 0.79 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>c,e,f</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of BOP</b><br>(Longâterm improvement in chronic and aggressive periodontitis)<br>Assessed with: periodontal probe </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>110<br>(2 RCTs<sup>a,b</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean percentage of BOP was 16.96%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 1.28% lower<br>(4.32 lower to 1.76 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>c,d,e</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Antimicrobial resistance</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included studies have not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>110<br>(2 RCTs<sup>a,b</sup>) </p> </td> <td align="left" valign="top" colspan="3" rowspan="1" class="table-tint table-highlight"> <p>1 study reported diarrhoea, headache or dizziness, metallic taste, and general unwellness by 4 participants from the intervention group and 3 from the control group. In 1 study none of the participants reported any adverse effects </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>c,e</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Patientâreported quality of life changes</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included studies have not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup><b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br><br><b>BOP:</b> bleeding on probing; <b>CAL:</b> clinical attachment level; <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>MICD:</b> minimally important clinical difference; <b>RCT:</b> randomized controlled trial; <b>SRP:</b> scaling and root planing </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD012568-bbs2-0035">Sampaio 2011</a>.<br><sup>b</sup><a href="./references#CD012568-bbs2-0024">Martande 2016</a>.<br><sup>c</sup>Downgraded by 1 level due to unclear risk of bias.<br><sup>d</sup>Downgraded by 1 level due to inconsistency.<br><sup>e</sup>Downgraded by 2 levels due to imprecision.<br><sup>f</sup>Downgraded by 2 levels due to inconsistency.<br><sup>g</sup>We decided to use an MD of 1 mm as the MICD for CAL and probing pocket depth, and 5% for percentage of closed pockets and percentage of BOP, and respective 95% CI not to cross the line of no effect. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD012568-tbl-0004"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 4.</span>Â <span class="table-title">Amoxicillin + clavulanate + SRP compared to SRP for the nonâsurgical treatment of periodontitis</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="7" rowspan="1" class="headercell"> <p>Amoxicillin + clavulanate + SRP <b>compared to SRP for the nonâsurgical treatment of periodontitis</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> adults with periodontitis (chronic)<br><b>Setting:</b> outpatient<br><b>Intervention:</b> amoxicillin + clavulanate + SRP<br><b>Comparison:</b> SRP </p> <p><b>Followâup:</b> â¥1 year </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Risk with control (SRP)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p>Risk difference with <b>a</b>moxicillin + clavulanate + SRP </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of closed pockets</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>Based on our definition of minimally important clinical difference (MICD)<sup>d</sup>, we found no evidence of a difference between intervention and control </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>CAL</b><br>(Longâterm improvement in chronic periodontitis)<br>Assessed with: periodontal probe in mm </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>21<br>(1 RCT<sup>a</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean CAL was 6.80 mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 0.10 mm higher<br>(0.51 lower to 0.71 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>b,c</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Probing pocket depth</b><br>(Longâterm improvement in chronic periodontitis)<br>Assessed with: periodontal probe in mm </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>21<br>(1 RCT<sup>a</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean probing pocket depth was 2.80 mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 0.10 mm higher<br>(0.17 lower to 0.37 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>b,c</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of BOP</b><br>(Longâterm improvement in chronic periodontitis)<br>Assessed with: periodontal probe </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>21<br>(1 RCT<sup>a</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean percentage of BOP was 0.20%</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 0%<br>(0.09 lower to 0.09 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>b,c</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Antimicrobial resistance</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>21<br>(1 RCT<sup>a</sup>) </p> </td> <td align="left" valign="top" colspan="3" rowspan="1" class="table-tint table-highlight"> <p>Included study reported diarrhoea in 2 participants from both groups</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>b,c</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Patientâreported quality of life changes</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup><b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br><br><b>BOP:</b> bleeding on probing; <b>CAL:</b> clinical attachment level; <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>MICD:</b> minimally important clinical difference; <b>RCT:</b> randomized controlled trial; <b>SRP:</b> scaling and root planing </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD012568-bbs2-0041">Winkel 1999</a>.<br><sup>b</sup>Downgraded by 1 level due to unclear risk of bias.<br><sup>c</sup>Downgraded by 2 levels due to imprecision (single study with limited number of participants).<br><sup>d</sup>We decided to use an MD of 1 mm as the MICD for CAL and probing pocket depth, and 5% for percentage of closed pockets and percentage of BOP, and respective 95% CI not to cross the line of no effect. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD012568-tbl-0005"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 5.</span>Â <span class="table-title">Doxycycline + SRP compared to SRP for the nonâsurgical treatment of periodontitis</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="7" rowspan="1" class="headercell"> <p><b>Doxycycline + SRP compared to SRP for the nonâsurgical treatment of periodontitis</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> adults with periodontitis (aggressive)<br><b>Setting:</b> outpatient<br><b>Intervention:</b> doxycycline + SRP<br><b>Comparison:</b> SRP </p> <p><b>Followâup:</b> â¥1 year </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Risk with control (SRP)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Risk difference with doxycycline + SRP</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of closed pockets</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>Based on our definition of minimally important clinical difference (MICD)<sup>d</sup>, </p> <p>only the results for probing pocket depth showed an MICD favouring doxycycline + SRP</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>CAL</b><br>(Longâterm improvement in aggressive periodontitis)<br>Assessed with: periodontal probe in mm </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>22<br>(1 RCT<sup>a</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean CAL was 5.90 mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 0.80 mm lower<br>(1.49 lower to 0.11 lower) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>b,c</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Probing pocket depth</b><br>(Longâterm improvement in aggressive periodontitis)<br>Assessed with: periodontal probe in mm </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>22<br>(1 RCT<sup>a</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean probing pocket depth was 5.20 mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 1 mm lower<br>(1.78 lower to 0.22 lower) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>b,c</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of BOP</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Antimicrobial resistance</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported adverse events</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Patientâreported quality of life changes</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup><b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br><br><b>BOP:</b> bleeding on probing; <b>CAL:</b> clinical attachment level; <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>MICD:</b> minimally important clinical difference; <b>RCT:</b> randomized controlled trial; <b>SRP:</b> scaling and root planing </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD012568-bbs2-0037">Sigusch 2001</a>.<br><sup>b</sup>Downgraded by 1 level due to unclear risk of bias.<br><sup>c</sup>Downgraded by 2 levels due to imprecision (single study with limited number of participants).<br><sup>d</sup>We decided to use an MD of 1 mm as the MICD for CAL and probing pocket depth, and 5% for percentage of closed pockets and percentage of BOP, and respective 95% CI not to cross the line of no effect. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD012568-tbl-0006"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 6.</span>Â <span class="table-title">Tetracycline + SRP compared to SRP for the nonâsurgical treatment of periodontitis</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="7" rowspan="1" class="headercell"> <p><b>Tetracycline + SRP compared to SRP for the nonâsurgical treatment of periodontitis</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> adults with periodontitis (aggressive)<br><b>Setting:</b> outpatient<br><b>Intervention:</b> tetracycline + SRP<br><b>Comparison:</b> SRP </p> <p><b>Followâup:</b> â¥1 year </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Risk with control (SRP)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Risk difference with tetracycline + SRP</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of closed pockets</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>Based on our definition of minimally important clinical difference (MICD)<sup>d</sup>, </p> <p>the results for CAL showed an MICD favouring</p> <p>tetracycline + SRP</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>CAL</b><br>(Longâterm improvement in aggressive periodontitis)<br>Assessed with: periodontal probe in mm </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>26<br>(1 RCT<sup>a</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean CAL was 4.40 mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 2.30 mm lower<br>(2.50 lower to 2.10 lower) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>b,c</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Probing pocket depth</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of BOP</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Antimicrobial resistance</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported adverse events</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Patientâreported quality of life changes</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup><b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br><br><b>BOP:</b> bleeding on probing; <b>CAL:</b> clinical attachment level; <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>MICD:</b> minimally important clinical difference; <b>RCT:</b> randomized controlled trial; <b>SRP:</b> scaling and root planing </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD012568-bbs2-0045">Zhang 2006</a>.<br><sup>b</sup>Downgraded by 1 level due to unclear risk of bias.<br><sup>c</sup>Downgraded by 2 levels due to imprecision (single study with limited number of participants).<br><sup>d</sup>We decided to use an MD of 1 mm as the MICD for CAL and probing pocket depth, and 5% for percentage of closed pockets and percentage of BOP, and respective 95% CI not to cross the line of no effect. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD012568-tbl-0007"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 7.</span>Â <span class="table-title">Clindamycin + SRP compared to SRP for the nonâsurgical treatment of periodontitis</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="7" rowspan="1" class="headercell"> <p><b>Clindamycin + SRP compared to SRP for the nonâsurgical treatment of periodontitis</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> adults with periodontitis (aggressive)<br><b>Setting:</b> outpatient<br><b>Intervention:</b> clindamycin + SRP<br><b>Comparison:</b> SRP </p> <p><b>Followâup:</b> â¥1 year </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Risk with control (SRP)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Risk difference with clindamycin + SRP</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of closed pockets</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>Based on our definition of minimally important clinical difference (MICD)<sup>d</sup>, the results for CAL and probing pocket depth showed an MICD favouring clindamycin + SRP </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>CAL</b><br>(Longâterm improvement in aggressive periodontitis)<br>Assessed with: periodontal probe in mm </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>21<br>(1 RCT<sup>a</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean CAL was 5.90 mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 1.70 mm lower<br>(2.40 lower to 1.00 lower) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>b,c</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Probing pocket depth</b><br>(Longâterm improvement in aggressive periodontitis)<br>Assessed with: periodontal probe in mm </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>21<br>(1 RCT<sup>a</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean probing pocket depth was 5.20 mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 1.80 mm lower<br>(2.47 lower to 1.13 lower) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>b,c</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of BOP</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Antimicrobial resistance</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported adverse events</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Patientâreported quality of life changes</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup><b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br><br><b>BOP:</b> bleeding on probing; <b>CAL:</b> clinical attachment level; <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>MICD:</b> minimally important clinical difference; <b>RCT:</b> randomized controlled trial; <b>SRP:</b> scaling and root planing </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD012568-bbs2-0037">Sigusch 2001</a>.<br><sup>b</sup>Downgraded by 1 level due to unclear risk of bias.<br><sup>c</sup>Downgraded by 2 levels due to imprecision (single study with limited number of participants).<br><sup>d</sup>We decided to use an MD of 1 mm as the MICD for CAL and probing pocket depth, and 5% for percentage of closed pockets and percentage of BOP, and respective 95% CI not to cross the line of no effect. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD012568-tbl-0008"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 8.</span>Â <span class="table-title">Doxycycline + SRP compared to metronidazole + SRP for the nonâsurgical treatment of periodontitis</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="7" rowspan="1" class="headercell"> <p><b>Doxycycline + SRP compared to metronidazole + SRP for the nonâsurgical treatment of periodontitis</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> adults with periodontitis (aggressive)<br><b>Setting:</b> outpatient<br><b>Intervention:</b> doxycycline + SRP<br><b>Comparison:</b> metronidazole + SRP </p> <p><b>Followâup:</b> â¥1 year </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Risk with metronidazole + SRP</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Risk difference with doxycycline + SRP</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of closed pockets</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>Based on our definition of minimally important clinical difference (MICD)<sup>d</sup>, the results for CAL and probing pocket depth showed an MICD favouring metronidazole + SRP </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>CAL</b><br>(Longâterm improvement in aggressive periodontitis)<br>Assessed with: periodontal probe in mm </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>27<br>(1 RCT<sup>a</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean CAL was 4 mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 1.10 mm higher<br>(0.36 higher to 1.84 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>b,c</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Probing pocket depth</b><br>(Longâterm improvement in aggressive periodontitis)<br>Assessed with: periodontal probe in mm </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>27<br>(1 RCT<sup>a</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean probing pocket depth was 3.20 mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 1 mm higher<br>(0.30 higher to 1.70 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>b,c</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of BOP</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Antimicrobial resistance</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported adverse events</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Patientâreported quality of life changes</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup><b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br><br><b>BOP:</b> bleeding on probing; <b>CAL:</b> clinical attachment level; <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>MICD:</b> minimally important clinical difference; <b>RCT:</b> randomized controlled trial; <b>SRP:</b> scaling and root planing </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD012568-bbs2-0037">Sigusch 2001</a>.<br><sup>b</sup>Downgraded by 1 level due to unclear risk of bias.<br><sup>c</sup>Downgraded by 2 levels due to imprecision (single study with limited number of participants).<br><sup>d</sup>We decided to use an MD of 1 mm as the MICD for CAL and probing pocket depth, and 5% for percentage of closed pockets and percentage of BOP, and respective 95% CI not to cross the line of no effect. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD012568-tbl-0009"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 9.</span>Â <span class="table-title">Clindamycin + SRP compared to metronidazole + SRP for the nonâsurgical treatment of periodontitis</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="7" rowspan="1" class="headercell"> <p><b>Clindamycin + SRP compared to metronidazole + SRP for the nonâsurgical treatment of periodontitis</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> adults with periodontitis (aggressive)<br><b>Setting:</b> outpatient<br><b>Intervention:</b> clindamycin + SRP<br><b>Comparison:</b> metronidazole + SRP </p> <p><b>Followâup:</b> â¥1 year </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Risk with metronidazole + SRP</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Risk difference with clindamycin + SRP</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of closed pockets</b> </p> </td> <td align="left" valign="top" colspan="4" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>Based on our definition of minimally important clinical difference (MICD)<sup>d</sup>, we found no evidence of a difference between the groups </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>CAL</b><br>(Longâterm improvement in aggressive periodontitis)<br>Assessed with: periodontal probe in mm </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>26<br>(1 RCT<sup>a</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean CAL was 4 mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 0.20 mm higher<br>(0.55 lower to 0.95 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>b,c</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Probing pocket depth</b><br>(Longâterm improvement in aggressive periodontitis)<br>Assessed with: periodontal probe in mm </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>26<br>(1 RCT<sup>a</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean probing pocket depth was 3.20 mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 0.20 mm higher<br>(0.38 lower to 0.78 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>b,c</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of BOP</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Antimicrobial resistance</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported adverse events</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Patientâreported quality of life changes</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup><b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br><br><b>BOP:</b> bleeding on probing; <b>CAL:</b> clinical attachment level; <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>MICD:</b> minimally important clinical difference; <b>RCT:</b> randomized controlled trial; <b>SRP:</b> scaling and root planing </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD012568-bbs2-0037">Sigusch 2001</a>.<br><sup>b</sup>Downgraded by 1 level due to unclear risk of bias.<br><sup>c</sup>Downgraded by 2 levels due to imprecision (single study with limited number of participants).<br><sup>d</sup>We decided to use an MD of 1 mm as the MICD for CAL and probing pocket depth, and 5% for percentage of closed pockets and percentage of BOP, and respective 95% CI not to cross the line of no effect. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD012568-tbl-0010"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 10.</span>Â <span class="table-title">Clindamycin + SRP compared to doxycycline + SRP for the nonâsurgical treatment of periodontitis</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="7" rowspan="1" class="headercell"> <p><b>Clindamycin + SRP compared to doxycycline + SRP for the nonâsurgical treatment of periodontitis</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> adults with periodontitis (aggressive)<br><b>Setting:</b> outpatient<br><b>Intervention:</b> clindamycin + SRP<br><b>Comparison:</b> doxycycline + SRP </p> <p><b>Followâup:</b> â¥1 year </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell table-tint"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Risk with doxycycline + SRP</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Risk difference with clindamycin + SRP</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of closed pockets</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>Based on our definition of minimally important clinical difference (MICD)<sup>d</sup>, we found no evidence of a difference between the groups </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>CAL</b><br>(Longâterm improvement in aggressive periodontitis)<br>Assessed with: periodontal probe in mm </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>23<br>(1 RCT<sup>a</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean CAL was 5.10 mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 0.90 mm lower<br>(1.62 lower to 0.18 lower) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>b,c</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Probing pocket depth</b><br>(Longâterm improvement in aggressive periodontitis)<br>Assessed with: periodontal probe in mm </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>23<br>(1 RCT<sup>a</sup>) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The mean probing pocket depth was 4.20 mm</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>MD 0.80 mm lower<br>(1.58 lower to 0.02 lower) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br>VERY LOW<sup>b,c</sup></p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Percentage of BOP</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Antimicrobial resistance</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported adverse events</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Patientâreported quality of life changes</b> </p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Included study has not reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup><b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br><br><b>BOP:</b> bleeding on probing; <b>CAL:</b> clinical attachment level; <b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>MICD:</b> minimally important clinical difference; <b>RCT:</b> randomized controlled trial; <b>SRP:</b> scaling and root planing </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD012568-bbs2-0037">Sigusch 2001</a>.<br><sup>b</sup>Downgraded by 1 level due to unclear risk of bias.<br><sup>c</sup>Downgraded by 2 levels due to imprecision (single study with limited number of participants).<br><sup>d</sup>We decided to use an MD of 1 mm as the MICD for CAL and probing pocket depth, and 5% for percentage of closed pockets and percentage of BOP, and respective 95% CI not to cross the line of no effect. </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
